Evicenter
Ozempic (semaglutide) in Type 2 diabetes
Manufacturer
Novo Nordisk Inc.
Questions
76
Last updated

All questions

Clinical trials: Ozempic (semaglutide) in type 2 diabetes

15 questions · 10 sources

Study results

How much weight do adults lose on Ozempic in type 2 diabetes trials?

How much did Ozempic lower A1C as monotherapy compared with placebo?

Applies to Type 2 diabetes in adults; Ozempic injection (pen)

Note: Table columns are placebo, OZEMPIC® 0.5 mg, and OZEMPIC® 1 mg, in that order; the difference-from-placebo row lists the 0.5 mg and 1 mg results.

Ozempic vs sitagliptin (Januvia): how much did each lower A1C?

Applies to Type 2 diabetes in adults; Ozempic injection (pen)

Note: Table columns are OZEMPIC® 0.5 mg, OZEMPIC® 1 mg, and sitagliptin, in that order; the difference-from-sitagliptin row lists the 0.5 mg and 1 mg results.

Ozempic vs exenatide ER (Bydureon): how much did each lower A1C?

Applies to Type 2 diabetes in adults; Ozempic injection (pen)

Note: Table columns are OZEMPIC® 1 mg and exenatide ER 2 mg, in that order.

Ozempic vs insulin glargine (Lantus): how much did each lower A1C (SUSTAIN 4)?

Applies to Type 2 diabetes in adults; Ozempic injection (pen)

Note: Table columns are OZEMPIC® 0.5 mg, OZEMPIC® 1 mg, and insulin glargine, in that order; the difference-from-insulin-glargine row lists the 0.5 mg and 1 mg results. Table 6 of the Prescribing Information reports the 30-week trial of 1089 patients described on this page as SUSTAIN 4.

How much did Ozempic lower A1C when added to basal insulin in SUSTAIN 5?

Applies to Type 2 diabetes in adults; Ozempic injection (pen)

Note: Table columns are placebo, OZEMPIC® 0.5 mg, and OZEMPIC® 1 mg, in that order; the difference-from-placebo row lists the 0.5 mg and 1 mg results. Table 8 of the Prescribing Information reports the 30-week basal insulin trial of 397 patients described on this page as SUSTAIN 5.

Does Ozempic 2 mg lower A1C more than Ozempic 1 mg (SUSTAIN FORTE)?

Applies to Type 2 diabetes in adults; Ozempic injection (pen)

Note: Table columns are OZEMPIC® 1 mg and OZEMPIC® 2 mg, in that order.

Ozempic 2 mg vs Mounjaro: is there a head-to-head trial?

Applies to Type 2 diabetes in adults; Ozempic injection (pen)

Note: This is the manufacturer's statement in the Ozempic dosing brochure, as captured on November 12, 2026.

Ozempic pill vs liraglutide (Victoza): how much did each lower A1C (PIONEER 4)?

Applies to Type 2 diabetes in adults; Ozempic tablets (pill)

Note: Table columns are placebo, semaglutide tablets 14 mg, and liraglutide 1.8 mg, in that order. Trial 4 of the Prescribing Information has the same design and enrollment (711 patients) as PIONEER 4.

Ozempic pill vs empagliflozin (Jardiance): how much did each lower A1C (PIONEER 2)?

Applies to Type 2 diabetes in adults; Ozempic tablets (pill)

Note: Table columns are semaglutide tablets 14 mg and empagliflozin 25 mg, in that order. This passage gives n=412 for semaglutide tablets 14 mg; the study design section of the same page and Table 5 of the Prescribing Information give 411. Trial 2 of the Prescribing Information has the same design and enrollment (822 patients) as PIONEER 2.

Ozempic pill vs sitagliptin (Januvia): how much did each lower A1C (PIONEER 3)?

Applies to Type 2 diabetes in adults; Ozempic tablets (pill)

Note: Table columns are semaglutide tablets 7 mg, semaglutide tablets 14 mg, and sitagliptin 100 mg, in that order. This passage gives n=466 for semaglutide tablets 7 mg; the study design section of the same page and Table 6 of the Prescribing Information give 465. Trial 3 of the Prescribing Information has the same design and enrollment (1864 patients) as PIONEER 3.

Cardiovascular outcomes

Does Ozempic lower the risk of heart attack, stroke, and cardiovascular death (SUSTAIN 6)?

Applies to Adults with type 2 diabetes and established cardiovascular disease; Ozempic injection

Does the Ozempic pill lower the risk of heart attack, stroke, and cardiovascular death (SOUL)?

Applies to Adults with type 2 diabetes at high risk for major cardiovascular events; semaglutide tablets

Note: Table 10 rows list placebo events, semaglutide tablets 14 mg events, and the hazard ratio (95% CI), in that order. Trial 7 of the Prescribing Information has the same design and enrollment (9,650 patients) as SOUL.

Kidney outcomes

Does Ozempic slow kidney disease progression in type 2 diabetes and CKD (FLOW)?

Applies to Adults with type 2 diabetes and chronic kidney disease; Ozempic injection

Note: On the CKD outcomes page, the 4.9% ARR footnote accompanies the primary composite endpoint result. The linked Ozempic® injection Prescribing Information (section 14.3) reports p=0.0003 for the primary composite endpoint.

Does Ozempic lower cardiovascular events and death in type 2 diabetes with CKD (FLOW)?

Applies to Adults with type 2 diabetes and chronic kidney disease; Ozempic injection

Note: Table 10 rows list placebo, OZEMPIC® 1 mg, the hazard ratio (95% CI), and the p-value, in that order. On the CKD outcomes page, the 2.2% ARR footnote accompanies the MACE result and the 2.5% ARR footnote accompanies the all-cause mortality result.